Argenica Therapeutics has secured a new US patent that positions its lead drug, ARG-007, at the forefront of preventing stroke not just in emergency rooms, but in operating theatres
Island Pharmaceuticals (ASX: ILA) has secured a U.S. patent for its lead antiviral drug ISLA-101, targeting dengue fever and bolstering its intellectual property portfolio until 2034.
ChemX continues to push forward by enhancing safety protocols and optimising control systems as it awaits key infrastructure for its pilot plant.